How Are Pharma Tablets Manufactured? Granulation to Packing

27th Jul 2026

How Are Pharma Tablets Manufactured? Granulation to Packing

How Are Pharma Tablets Manufactured? Granulation to Packing

A tablet looks simple, small, uniform disc you swallow with water. But getting from raw active pharmaceutical ingredient (API) powder to that finished tablet involves five distinct manufacturing stages, each with its own quality checkpoints. Understanding this process helps pharma brands, distributors, and procurement teams ask the right questions when evaluating a manufacturing partner.

This guide walks through how tablets are actually made the science behind each stage, and why skipping steps or cutting corners shows up later as dissolution failures, friability issues, or stability complaints.

1. Formulation and Pre-Formulation Study

Before any powder is mixed, a formulation team studies the API’s physical and chemical properties solubility, particle size, moisture sensitivity, and compatibility with excipients (binders, fillers, disintegrants). This stage decides which manufacturing route the tablet will follow: wet granulation, dry granulation, or direct compression.

Getting this decision wrong is the single biggest cause of tablet manufacturing failures downstream, a moisture-sensitive API run through wet granulation, for example, can degrade before it ever reaches compression.

2. Granulation Turning Powder Into Uniform Granules

Raw powders don’t compress well on their own; they’re prone to segregation and poor flow. Granulation binds fine powder particles into larger, more uniform granules that compress consistently.

Wet granulation uses a liquid binder (often in a high-shear mixer) to bind powders together, followed by drying. It works well for formulations that can tolerate moisture and heat, and generally produces strong, well-bound tablets.

Dry granulation (roller compaction) compresses powder into a solid sheet or “ribbon” without any liquid, then mills it into granules. This route is essential for moisture- or heat-sensitive APIs.

Fluid bed granulation suspends powder in a stream of air while spraying binder solution, giving excellent flow properties and more uniform dissolution — often preferred for modified-release formulations.

Each method changes tablet dissolution behavior, so the choice isn’t cosmetic it directly affects how a drug performs in the body.

3. Compression, Forming the Tablet

Granules move to a rotary tablet press, where multiple punches and dies compress the material into tablets at high speed — often tens of thousands of tablets per hour on commercial-scale presses.

During compression, in-process quality checks run continuously:

  • Weight variation — every tablet must fall within a tight weight tolerance
  • Hardness — tablets must withstand handling and transport without crumbling
  • Thickness — consistency here affects packaging fit and dose uniformity
  • Friability — resistance to chipping and abrasion during coating and packing

Manufacturers sample tablets at defined intervals throughout the compression run, not just at the start and end, to catch drift before an entire batch is affected.

4. Coating, Function, Not Just Appearance

Not every tablet is coated for the same reason, and this is where a lot of confusion exists among buyers:

  • Film coating is a thin polymer layer applied mainly for taste-masking, ease of swallowing, and light/moisture protection. It doesn’t significantly change how or where the drug releases.
  • Enteric coating uses pH-sensitive polymers designed specifically to survive stomach acid and dissolve only in the intestine — critical for acid-labile APIs or drugs that irritate the stomach lining.
  • Extended-release (ER) coatings use hydrophilic or hydrophobic polymer matrices to control the rate of drug release over several hours, rather than releasing the full dose immediately.

Coating is applied in perforated coating pans under controlled temperature, airflow, and spray rate small deviations here can change the entire release profile of the drug.

5. Quality Control Testing Before Release

Before any batch is packed, it goes through in-house analytical testing:

  • Dissolution testing — measures how much drug releases into solution over time, simulating how it behaves in the body
  • Disintegration testing — measures how quickly the tablet breaks down
  • Assay (HPLC) — confirms the actual drug content matches the labeled strength
  • Content uniformity — confirms every tablet in the batch has a consistent dose
  • Related substances/impurities testing — screens for degradation products

A Certificate of Analysis (COA) is only issued once every parameter passes specification — this is the document that should accompany every batch a buyer receives.

6. Packaging — Protecting the Tablet After Manufacturing

Manufacturing quality can still be undermined by poor packaging. Common formats include:

  • Alu-Alu cold form blister — aluminum on both sides, offering the highest moisture and light barrier, used for hygroscopic or photosensitive APIs
  • Alu-PVC blister — standard barrier, suitable for moisture-tolerant formulations
  • Alu-Alu strips — common for unit-dose and sample packs

Stability studies (conducted under ICH-aligned conditions across different climate zones) determine which packaging format a given formulation actually needs — this shouldn’t be a cost-driven decision made after the fact.

Why This Process Matters When Choosing a Manufacturing Partner

Every stage above is a point where quality can be built in — or lost. When evaluating a tablet manufacturing partner, it’s worth asking specifically:

  • Which granulation technologies does their facility operate, and how is the choice matched to your API?
  • Is in-process testing done at defined intervals during compression, or only at batch release?
  • Are stability studies conducted under ICH-aligned zones relevant to your target market?
  • Is the Certificate of Analysis issued from an in-house lab, or outsourced?

If you’re evaluating manufacturing partners in India for WHO-GMP certified tablet production across these formats, you can review 9M India’s tablet manufacturing capabilities — including granulation technologies, coating types, and packaging formats covered in this guide.


Frequently Asked Questions

What is the difference between wet and dry granulation? Wet granulation uses a liquid binder and drying step, suited to moisture-tolerant formulations. Dry granulation (roller compaction) uses pressure alone, making it suitable for moisture- or heat-sensitive APIs.

Why are some tablets enteric-coated? Enteric coating protects acid-labile drugs from stomach acid or protects the stomach lining from irritating drugs, releasing the dose only once it reaches the intestine.

What tests are done before a tablet batch is released? Standard release testing includes dissolution, disintegration, hardness, friability, weight variation, assay, and content uniformity, with results documented in a Certificate of Analysis.

How long does the tablet manufacturing process take? Depending on formulation complexity, granulation method, and stability requirements, the process from raw material to packed batch typically takes several days to a few weeks, excluding release testing turnaround.

Looking for something specific?

At 9M India Limited, trust through quality, transparency, performance.